Northwest Biotherapeutics Secures US$1.0 Million Debt Financing

in

BETHESDA, Md., Oct. 2 /PRNewswire-FirstCall/ -- Northwest Biotherapeutics, Inc. , today announced that it has entered into a Loan Agreement and Promissory Note (the "Note") with SDS Capital Group SPC, Ltd ("SDS"). Under the Note, SDS has loaned the Company US$1,000,000. The Note is an unsecured obligation of the Company and accrues interest at the rate of 12% per year. The term of the Note...